Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-06-19
2007-06-19
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S044000, C564S057000, C560S312000, C548S142000, C514S363000, C514S507000, C514S575000, C514S594000, C514S603000
Reexamination Certificate
active
10547299
ABSTRACT:
The invention relates to new 2,2,3,3-tetramethylcyclopropane carboxamide derivative compounds, pharmaceutical compositions thereof and uses thereof for treating psychotic disorders, neurodegenerative diseases, epilepsy and pain.
REFERENCES:
patent: 5585358 (1996-12-01), Bialer et al.
patent: 5880157 (1999-03-01), Sterling et al.
patent: 6323365 (2001-11-01), Blaler et al.
patent: 6417399 (2002-07-01), Bialer et al.
patent: 6555585 (2003-04-01), Shirvan et al.
patent: 6630602 (2003-10-01), Bialer et al.
patent: 6958416 (2005-10-01), Bialer et al.
patent: 6969732 (2005-11-01), Bialer et al.
patent: 2002/0052418 (2002-05-01), Shirvan et al.
patent: 2002/0115718 (2002-08-01), Chen et al.
patent: 2004/0204495 (2004-10-01), Shirvan et al.
patent: 95/09835 (1995-04-01), None
patent: 95/21814 (1995-08-01), None
patent: 98/30536 (1998-07-01), None
patent: 99/48859 (1999-09-01), None
patent: 99/54282 (1999-10-01), None
patent: 03/064374 (2003-08-01), None
patent: 2004/105746 (2004-12-01), None
patent: 2005/009430 (2005-02-01), None
patent: 7400202 (1974-11-01), None
Gao et al, J. Med Chem, 1995, vol. 38, pp. 2292-2301.
Agam, G., et al., “Myo-inositol-1-phosphate (MIP) Synthase: A Possible New Target for Antibipolar Drugs”, Bipolar Disorders (2002), pp. 15-20, Suppl. 1.
Bialer, M., et al., “New Antiepileptic Drugs Currently in Clinical Trials: Is There a Strategy in Their Development?”, Therapeutic Drug Monitoring (2002), pp. 85-90, vol. 24, No. 1.
Bialer, M., et al., “Pharmacokinetic Analysis and Antiepileptic Activity of Tetra-Methylcyclopropane Analogues of Valpromide”, Pharmaceutical Research (1996), pp. 284-289, vol. 13, No. 2.
Bialer, M., et al., “Pharmacokinetic Consideration in the Design of Better and Safer New Antiepileptic Drugs”, Journal of Controlled Release (1999), pp. 187-192, vol. 62.
Bialer, M., et al., “Pharmacokinetic of a Valpromide Isomer, Valnoctamide, in Healthy Subjects”, European Journal of Clinical Pharmacology (1990), pp. 289-291, vol. 38.
Blotnik, S., et al., “Disposition of Two Tetramethylcyclopropane Analogues of Valpromide in the Brain, Liver, Plasma and Urine of Rats”, European Journal of Pharmaceutical Sciences (1998), pp. 93-98, vol. 6.
Gao, J., et al., “Increasing Binding Constants of Ligands to Carbonic Anhydrase by Using Greasy Tails”, Journal of Medicinal Chemistry (1995), pp. 2292-2301, vol. 38, No. 13.
Greenberg, M., et al., “Inhibition of Myo-Inositol-Phosphate Synthase by Valproate; a Mechanism for Mood Stabilization?”, European Neuropsychopharmacology (2003), pp. S107-S108, vol. 13, Supplement 4.
Huber, A., et al., “Siezure Suppression by Adenosine A2A Receptor Activation in a Rat Model of Audiogenic Brainstem Epilepsy”, Neuroscience Letters (2002), pp. 289-292, vol. 329.
Isoherranen, N., et al., “Anticonvulsant Profile and Teratogenicity of N-methyl-tetramethylcyclopropyl Carboxamide: A new Antiepileptic Drug”, EPILEPSY (2002), pp. 115-126, vol. 43.
Isoherranen, N., et al., “New CNS-active Drugs Which are Second-Generation Valproic Acid: Can They Lead to the Development of Magic Bullet?”, Current Opinion in Neurology (2003), pp. 203-211, vol. 16.
Malhotra, J. et al., “Effect of Adenosine Receptor Modulation on Pentylenetetrazole-Induced Seizures in Rats”, British Journal of Pharmacology (1997), pp. 282-288, vol. 120.
Sheen, K., et al., “Signs of Neuropathic Pain Depend on Signals From Injured Nerve Fibers in a Rat Model”, Brain Research (1993), pp. 62-68, vol. 610.
Shuto, S., et al., “Synthesis and Biological Activity of Conformationally Restricted Analogs of Milnacipran: (1S, 2R)-1-Phenyl-2-U(S)-1-Aminopropyl-N,N-Diethylcyclopropanecarboxamide, An Efficient Noncompetitive N-methyl-D-aspartic acid receptor antagonist”, Journal of Medicinal Chemistry (1996), pp. 4844-4852, vol. 39.
Shuto, S., et al. “(Plus or minus)-(z)-2-(aminomethyl)-1-phenylcyclopropanecarboxamide Derivatives as a New Prototype of NMDA Receptor Antagonists”, Journal of Medicinal Chemistry (1995), pp. 2964-2968, vol. 38.
Spiegelstein, O., et al., “Enantioselective Synthesis and Teratogenicity of Propylisopropyl Acetamide, a CNS Active Chiral Amide Analogue of Valproic Acid”, CHIRALITY (1999), pp. 645-650, vol. 11.
White, H.S., et al., “General principles-Discovery and Preclinical Development of Antiepileptic Drugs”, Antiepileptic Drugs (2002), 5th edition, RH Levy, RH Mattson, BS Meldrum, E Perucca (eds), Lippincott William & Wilkins, Philadelphia, pp. 36-48.
Bialer Meir
Kaufmann Dan
Sobol Eyal
Yagen Boris
Browdy and Neimark PLLC
Kumar Shailendra
Yissum Research Development Company of the Hebrew University of
LandOfFree
Amide derivatives of 2,2,3,3-tetramethylcyclopropane... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives of 2,2,3,3-tetramethylcyclopropane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives of 2,2,3,3-tetramethylcyclopropane... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828946